…jective To broadly characterise non-coding driver mutations for pancreatic ductal adenocarcinoma (PDAC).Design Using mutation calls from whole-genome sequence data in …
PDAC
This disease is selected. Its supporting articles are shown below.
Articles mentioning PDAC
32 articles · page 3 of 3…ase 6 (NSUN6), an m 5C methyltransferase, in shaping the TME of pancreatic ductal adenocarcinoma (PDAC).Design The clinical significance of NSUN6 was assessed in human…
…Pancreatic ductal adenocarcinoma (PDAC) represents approximately 90% of all malignant tumours in…
…nosis and therapeutic resistance in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), including resistance to immunotherapy. We previously de…
…Background Pancreatic ductal adenocarcinoma (PDAC) is a malignant neoplasm of the pancreas characterized by late-s…
…Background Pancreatic ductal adenocarcinoma (PDAC) remains an indication of immense clinical need. KRAS mutation i…
…Background Oncogenic RAS mutations are prevalent in solid tumors and play a central role in driving immune evasion. While RAS in…
…e include adult participants, aged ≥18 years, in three cohorts: pancreatic ductal adenocarcinoma; benign pancreatic controls (chronic pancreatitis or new-onset …